Investment Rating - The report maintains an "Outperform" rating for the industry [4] Core Insights - The precious metals sector is experiencing an increase in prices due to rising macroeconomic and geopolitical risks, with silver prices accelerating [1][9] - Industrial metals are expected to see price fluctuations due to interest rate expectations and geopolitical tensions, particularly affecting copper and aluminum [2][11] - The lithium carbonate market is witnessing a significant price increase, although spot trading remains sluggish [3][17] - The rare earth market is seeing rapid price increases driven by supply tightening, but demand has not kept pace, leading to a divided sentiment in the industry [3][21] Summary by Sections Precious Metals - The report highlights that geopolitical tensions and macroeconomic factors are enhancing the safe-haven appeal of precious metals, particularly gold and silver [1][9] - Key stocks to watch include Zijin Mining, Zhongjin Lingbao, and others in the A-share and H-share markets [10] Industrial Metals - Copper prices are experiencing volatility due to macroeconomic disturbances and geopolitical risks, with domestic inventories reaching a ten-year high [11][15] - Aluminum prices are expected to remain stable in the short term, but demand is under pressure due to high prices and seasonal factors [15][16] New Energy Metals - Lithium carbonate production is slightly increasing, but overall market sentiment remains strong due to optimistic demand forecasts, particularly in the energy storage sector [17] - Key stocks in the lithium sector include Ganfeng Lithium and others [17] Other Minor Metals - The rare earth market is seeing price increases driven by supply constraints, particularly in recycled materials, but demand has not matched this growth [21] - Key stocks to monitor include Northern Rare Earth and others in the rare earth sector [21] Market Review - The overall non-ferrous metal index increased by 3.0%, outperforming the broader market [22] - Notable stock performances include Hunan Silver, which saw a 41.14% increase, while West Materials experienced a 16.96% decline [32] Valuation - The current PE ratio for the non-ferrous metal industry is 35.36, indicating potential for valuation increases in copper and aluminum sectors due to supply constraints and rising demand for green metals [37]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 20% against the market benchmark within the next six months [6][16]. Core Insights - The company anticipates a net profit increase of at least 30% for the fiscal year ending December 31, 2025, compared to the previous year, driven by increased sales of 1.74 refractive index lenses and other multifunctional products, along with improved operational efficiency and financing structure [3][4]. - The company is positioned as a leading manufacturer of high-refractive lenses in China, with significant cost advantages due to its scale and production capabilities. It is also expanding its overseas production capacity to mitigate tariff impacts [4][5]. - The smart glasses market is projected to grow significantly, with a 110% year-on-year increase in shipments expected in the first half of 2025. The company has secured partnerships with major players in the smart glasses sector, enhancing its revenue potential from XR (extended reality) business [5][6]. Financial Projections - Revenue growth rates are forecasted at 20% for 2025, 21% for 2026, and 19% for 2027, with corresponding net profit growth rates of 31%, 25%, and 23% respectively. The report adjusts previous estimates slightly upward [6][10]. - The company's earnings per share (EPS) is projected to increase from 0.89 in 2024 to 1.79 by 2027, reflecting strong profitability growth [6][10]. Financial Data Summary - The company’s main revenue is expected to reach RMB 2,477 million in 2025, with a net profit of RMB 559 million. By 2027, revenue is projected to grow to RMB 3,582 million, with net profit reaching RMB 861 million [7][10]. - The report highlights a consistent improvement in gross margin, expected to rise from 38.6% in 2024 to 42.1% by 2027, indicating enhanced operational efficiency [10].

Investment Rating - The industry rating is "Outperform the Market" [7] Core Insights - The report highlights a strong recovery in investment and financing activities in the CXO sector, with significant growth in both primary and secondary markets for biotech [4][18][23] - The JPM conference indicated a positive outlook for 2026, with companies expressing optimism about demand recovery and operational efficiency improvements [4][28] - The report emphasizes the importance of technological innovation in the pharmaceutical sector for 2026, focusing on innovative drugs and medical devices [5][32] Summary by Sections Investment Opportunities and Trends - Primary market financing for overseas biotech reached $8.72 billion in Q4 2025, showing a year-on-year decrease of 2.4% but a quarter-on-quarter increase of 21% [4][18] - In January 2026, primary market financing totaled $3.34 billion, indicating a strong recovery [4][18] - Secondary market financing for overseas biotech in Q4 2025 was $19.28 billion, a year-on-year increase of 111% and a quarter-on-quarter increase of 149.5% [4][23] - The report notes that companies like WuXi AppTec and Danaher exceeded performance expectations, with a general recovery in demand for Pharma and Biotech orders [4][28] Market Performance Review - The CITIC Pharmaceutical Index fell by 0.72% from January 12 to January 16, 2026, underperforming the CSI 300 Index by 0.2 percentage points [3][32] - The pharmaceutical sector has seen a 6.9% increase since the beginning of 2026, outperforming the CSI 300 Index by 4.7 percentage points [3][32] - The top-performing stocks during this period included Baolai Te (+48.8%), Hualan Biological Engineering (+32.7%), and Tianzhihang (+27.7%) [3][47] Company Performance and Recommendations - The report suggests focusing on companies such as WuXi AppTec, Beigene, and others for potential investment opportunities in 2026 [5][54] - The report outlines a strategy for innovative drugs, emphasizing revenue realization, unexpected business development, and cutting-edge technology platforms [5][32] - The medical device sector is highlighted for its potential in equipment replenishment and innovative consumables benefiting from centralized procurement [5][32]

行 华福证券 基础化工 2026 年 01 月 18 日 业 研 究 行 业 定 期 报 告 基础化工 行业周报：巴斯夫湛江一体化基地聚乙烯装置投 产后首车交付，SABIC 出售两大资产 投资要点： 本周板块行情：本周，上证综合指数下跌 0.45%，创业板指数上涨 1%， 沪深 300 下跌 0.57%，中信基础化工指数上涨 1.27%，申万化工指数上涨 0.9%。 化工各子行业板块涨跌幅：本周，化工板块涨跌幅前五的子行业分别为电 子化学品(5.16%)、橡胶助剂(4.66%)、钾肥(4.23%)、合成树脂(3.67%)、磷肥及 磷化工(2.85%)；化工板块涨跌幅后五的子行业分别为改性塑料(-4.01%)、钛白 粉(-2.84%)、橡胶制品(-1.43%)、轮胎(-1.18%)、纯碱(-0.85%)。 本周行业主要动态： 巴斯夫湛江一体化基地聚乙烯装置投产后首车交付。巴斯夫湛江一体化 基地再度迎来重要里程碑全新聚乙烯(PE)装置正式投产，并顺利完成首车 产品交付。2026 年 1 月 8 日，首批巴聚赋聚乙烯产品由专业运输车辆从湛 江基地发出，准时抵达客户仓库。这一成果不仅彰显了巴斯夫"以客户为 中心"的服 ...

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [14]. Core Insights - Meta has signed a nuclear power agreement exceeding 6 GW, becoming the largest nuclear power purchaser among large tech companies. The agreement includes significant small modular reactor (SMR) projects, supporting Oklo's project in Ohio with up to 1.2 GW of power and TerraPower's two small reactors with a future purchase agreement for 2.1 GW [3][4]. - The demand for electricity in U.S. data centers is projected to increase by at least 30% by 2030, making electricity a bottleneck for AI industry development. Nuclear power, being clean and stable, provides long-term energy security for Meta's AI data centers, promoting the implementation of new small reactor technologies and aligning with low-carbon goals [4][5]. Summary by Sections Nuclear Power Agreements - Meta's agreements include collaborations with Oklo and TerraPower, focusing on small modular reactors to meet the growing energy demands of AI data centers [3][4]. Energy Demand and AI - The report highlights the increasing electricity consumption in data centers and positions small modular reactors as a key solution to address the energy needs of AI technologies [4][5]. Investment Opportunities - The report suggests monitoring several companies involved in the SMR sector, including: 1. Jingye Intelligent, which plans to establish an SMR subsidiary focused on AI data center power supply [5]. 2. Jiadian Co., whose helium fan is the only power device for the fourth-generation high-temperature gas-cooled reactor [5]. 3. Guoguang Electric, which provides critical components for ITER projects [5]. 4. Lanshi Heavy Industry, covering upstream nuclear fuel systems to downstream spent fuel processing [5]. 5. Kexin Electromechanical, which has developed high-temperature gas-cooled reactor products [5]. 6. Hailu Heavy Industry, servicing various reactor types including third and fourth generation [5]. 7. Jiangsu Shentong, which has secured over 90% of orders for nuclear-grade valves in new nuclear power projects in China [5].

Investment Rating - The report maintains an "Outperform" rating for the industry [4] Core Insights - December home sales in the U.S. exceeded expectations, indicating a potential improvement in consumer demand related to the real estate chain [3] - META aims to double the production capacity of AI RAY-BAN glasses to 20 million units by 2026, suggesting investment opportunities in companies like 康耐特光学, 明月镜片, and 博士眼镜 [3] - Despite weak domestic consumption in home goods and stationery, leading companies are at historical low stock prices, presenting opportunities for valuation recovery [3] Summary by Sections Real Estate and Related Consumption - U.S. home sales in December reached an annualized total of 4.35 million units, up 1.4% year-on-year and 5.1% month-on-month, surpassing expectations of 4.22 million units [6] - The Trump administration has announced plans to enhance housing affordability, including a proposal to prohibit institutional investors from purchasing single-family rental homes [6] Home Goods and Furniture - The home goods sector continues to face challenges, with a reported 4.4% year-on-year decline in sales for large-scale home goods markets in December [41] - The furniture manufacturing industry saw a cumulative revenue decline of 9.1% year-on-year from January to November [43] Paper and Packaging - As of January 16, 2026, prices for various paper products showed mixed trends, with double glue paper at 4725 CNY/ton (unchanged) and corrugated paper down to 2725 CNY/ton (a decrease of 95.63 CNY/ton) [48] - The report highlights a decline in the revenue of the paper and paper products industry, with a cumulative year-on-year revenue drop of 2.7% from January to November [63] Consumer Goods - The medical segment of the consumer goods sector is expected to see growth, with strategic initiatives aimed at enhancing product offerings and operational excellence [5] - The stationery sector is recommended for investment, particularly in companies like 晨光股份, which is expected to maintain steady growth [5] New Tobacco Products - The report notes ongoing investigations into Chinese competitors by British American Tobacco regarding electronic cigarette regulations in the U.S., indicating potential market shifts [10]

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% over the next 6 months [13]. Core Insights - The report highlights that Huadian Co. is establishing a cutting-edge technology platform to accelerate the implementation of CoWoP technology, with plans to invest a total of $300 million in a high-density optical integrated circuit board project, which is expected to add an annual production capacity of 1.3 million high-density optical integrated circuit boards once fully operational [3][5]. - The glass substrate industry is approaching a critical transition from technology validation to early-stage mass production, with expectations for small-scale commercial shipments to begin by 2026. The compound annual growth rate (CAGR) for semiconductor glass wafer shipments is projected to exceed 10% from 2025 to 2030 [4]. - The demand for AI-driven servers, data storage, and high-speed network infrastructure is creating new growth opportunities in the PCB market, as the supply of related high-end products is currently insufficient. The development of AI and network infrastructure will require more complex, higher-performance, and high-density interconnect (HDI) PCB products [5]. Summary by Sections - **Investment Highlights**: Huadian Co. is set to invest $300 million in a project for high-density optical integrated circuit boards, aiming for a production capacity of 1.3 million units annually [3]. - **Glass Substrate Commercialization**: The glass substrate industry is on the verge of commercial viability, with significant players like SK, LG, and Samsung expanding their collaborations with material and process suppliers [4]. - **Market Opportunities**: The growth in AI and network infrastructure is expected to drive demand for advanced PCB products, presenting new opportunities for the industry [5]. - **Recommended Companies**: The report suggests focusing on PCB equipment consumables and PCBA equipment companies, including Dazhu CNC, Ding Tai High-Tech, and others [6].

行 半导体 2026 年 01 月 18 日 业 研 究 行 业 定 期 报 告 半导体 台积电 CAPEX 指引超预期，关注长鑫上市进展 ——大科技海外周报第 2 期 投资要点： 台积电 CAPEX 超预期，AI 需求旺盛，看好算力产业链。 4Q25 超预期：台积电于 1 月 15 日召开 4Q25 法说会，公司 4Q25 营收达 337 亿美元，YoY +25.5%，QoQ +1.9%，超出前期指引上线（332 亿至 334 亿）；归母净利润 5057.4 亿新台币，YoY +35%，毛利率提升 至 62.3%，超指引上线（59%至 61%），净利率提升至 48.3%。 CAPEX 指引超预期：公司指引 2026 年营收预计增长近 30%，1Q26 指引为 346 亿-358 亿美元（中值环比增 4.4%），公司 2026 年 CAPEX 预计在 520 至 560 亿美元之间，同比大幅增长，创历史新高。 AI 需求旺盛：公司在法说会中表示，经过和下游客户反复沟通验 证，确认 AI 需求是真实且强劲的。公司上调了 2024-2029 年 AI 加速 器收入 CAGR 指引至 55%~59%。 看好算力产业 ...

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [6][13]. Core Insights - Merge Labs has successfully completed a seed round financing of approximately $250 million, achieving a valuation of $850 million. This financing was led by OpenAI, with its CEO Sam Altman participating as a co-founder and investor. Unlike mainstream brain-machine interface technologies, Merge Labs focuses on a non-invasive or minimally invasive approach centered on ultrasound, bypassing the traditional "electrode-neuron" paradigm [3][4]. - The brain-machine interface market is projected to grow rapidly, with the global market size expected to reach approximately $2.62 billion in 2024 and $2.94 billion in 2025, potentially growing to $12.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% over the next decade. In China, the market size is anticipated to be 3.2 billion yuan in 2024, increasing to 6.14 billion yuan by 2028 [5]. Summary by Sections Investment Highlights - Merge Labs' ultrasound-based technology aims to balance between non-invasive (safe but limited resolution) and invasive (clear signals but with surgical risks and ethical concerns) methods. The unique potential of ultrasound's deep penetration and "soft interface" concept is highlighted, although the technology is still in the laboratory research phase and faces multiple unresolved challenges [4]. Market Outlook - The report emphasizes the strategic importance of brain-machine interfaces as a key sector in the "14th Five-Year Plan," aiming to drive new economic growth points. The industry is expected to gain momentum over the next decade, potentially creating a new high-tech industry in China [5]. Recommended Companies - The report suggests monitoring companies such as Rock Mountain Technology, Hanwei Technology, Sanbo Brain Science, Innovation Medical, Dongfang Zhongke, Xiangyu Medical, Entropy Technology, Chengyitong, Weisi Medical, Meilan De, Aipeng Medical, and Beiyikang for potential investment opportunities [5].

投资要点： 一、中期选举有何看点？ 宏 观 专 题 参议院更换约 1/3，众议院全换。中期选举是夹在两次总统选举间 的国会换届选举。美国国会是美国的立法机构，此次选举将决定 2027 年-2028 年间两党在国会的席位数分配，影响特朗普本轮任期后半程的 政策落地。参议院中将有约三分之一席位的议员到期改选，而众议院 席位全部重选。参众两院的选举流程基本一致，先在各州开展初选， 推出席位的党派候选人，然后在 11 月 3 日最终投票。区别主要在于代 表选区不同。参议院的席位按照每个州 2 位固定分配，而众议院席位 按照依据人口比例划分选区。 悬念主要在众议院。当前国会中，共和党横扫参众两院。在参议 院变更的 35 个席位中，约 16 个席位为共和党的坚固票仓。民主党若 想要扭转局势较为困难，参议院或继续由共和党或继续执掌。而众议 院的形势胶着，民主党只需夺回 3 个席位即可夺取控制权。 关注 3 月"超级星期二"和 6 月选举高峰期。首先，是 3 月 3 日 的"超级星期二"。在这天，将有 3 个州将最早开启初选。其中，北卡 来罗纳州有一个摇摆的参议院席位；而德克萨斯州在众议院有 38 个席 位，规模仅次于加州。 ...